» Articles » PMID: 29522462

Venomics-Accelerated Cone Snail Venom Peptide Discovery

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2018 Mar 10
PMID 29522462
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

Cone snail venoms are considered a treasure trove of bioactive peptides. Despite over 800 species of cone snails being known, each producing over 1000 venom peptides, only about 150 unique venom peptides are structurally and functionally characterized. To overcome the limitations of the traditional low-throughput bio-discovery approaches, multi-omics systems approaches have been introduced to accelerate venom peptide discovery and characterisation. This "venomic" approach is starting to unravel the full complexity of cone snail venoms and to provide new insights into their biology and evolution. The main challenge for venomics is the effective integration of transcriptomics, proteomics, and pharmacological data and the efficient analysis of big datasets. Novel database search tools and visualisation techniques are now being introduced that facilitate data exploration, with ongoing advances in related omics fields being expected to further enhance venomics studies. Despite these challenges and future opportunities, cone snail venomics has already exponentially expanded the number of novel venom peptide sequences identified from the species investigated, although most novel conotoxins remain to be pharmacologically characterised. Therefore, efficient high-throughput peptide production systems and/or banks of miniaturized discovery assays are required to overcome this bottleneck and thus enhance cone snail venom bioprospecting and accelerate the identification of novel drug leads.

Citing Articles

Systemic antihyperalgesic effect of a novel conotoxin from in an inflammatory pain model.

Lopez-Carrillo J, Bernaldez-Sarabia J, Pawar T, Jimenez S, Duenas S, Figueroa-Montiel A Front Pain Res (Lausanne). 2025; 5:1500789.

PMID: 39925365 PMC: 11802583. DOI: 10.3389/fpain.2024.1500789.


In Silico Conotoxin Studies: Progress and Prospects.

Li R, Hasan M, Wang D Molecules. 2025; 29(24.

PMID: 39770149 PMC: 11677113. DOI: 10.3390/molecules29246061.


Predatory and Defensive Strategies in Cone Snails.

Ratibou Z, Inguimbert N, Dutertre S Toxins (Basel). 2024; 16(2).

PMID: 38393171 PMC: 10892987. DOI: 10.3390/toxins16020094.


Design of Bioengineered Peptides/Proteases as Anti-cancer Reagents with Integrated Omics and Machine Learning Approaches.

Zuo W, Kwok H Methods Mol Biol. 2023; 2747:295-309.

PMID: 38038948 DOI: 10.1007/978-1-0716-3589-6_22.


Targeting Dysregulated Ion Channels in Liver Tumors with Venom Peptides.

Achimba F, Faezov B, Cohen B, Dunbrack R, Holford M Mol Cancer Ther. 2023; 23(2):139-147.

PMID: 38015557 PMC: 10831335. DOI: 10.1158/1535-7163.MCT-23-0256.


References
1.
Rodriguez A, Dutertre S, Lewis R, Mari F . Intraspecific variations in Conus purpurascens injected venom using LC/MALDI-TOF-MS and LC-ESI-TripleTOF-MS. Anal Bioanal Chem. 2015; 407(20):6105-16. DOI: 10.1007/s00216-015-8787-y. View

2.
Calvete J . Venomics: integrative venom proteomics and beyond. Biochem J. 2017; 474(5):611-634. DOI: 10.1042/BCJ20160577. View

3.
Ivosev G, Burton L, Bonner R . Dimensionality reduction and visualization in principal component analysis. Anal Chem. 2008; 80(13):4933-44. DOI: 10.1021/ac800110w. View

4.
Fox E, Reid-Bayliss K, Emond M, Loeb L . Accuracy of Next Generation Sequencing Platforms. Next Gener Seq Appl. 2015; 1. PMC: 4331009. DOI: 10.4172/jngsa.1000106. View

5.
Clark R, Jensen J, Nevin S, Callaghan B, Adams D, Craik D . The engineering of an orally active conotoxin for the treatment of neuropathic pain. Angew Chem Int Ed Engl. 2010; 49(37):6545-8. DOI: 10.1002/anie.201000620. View